Frequency, nature and risk factors of lesions of the esophagogastroduodenal zone in patients with bronchial asthma
Abstract
The questionnaire screening of patients with bronchial asthma showed that the majority of patients do not focus on existing complaints from the digestive organs and refer them to manifestations of their underlying disease. Esophagogastroduodenalfi broscopic examination of patients with asthma for the fi rst time refl ected the presence of Esophagogastroduodenal zone (EGDZ) pathology in 67.3% of patients, of which erosive-ulcerative lesions were detected in 21.3% of cases and catarrhal lesions — in 46% of cases. It is necessary to pay attention to the fact that the resolving factors for the development of the pathology of the Esophagogastroduodenal zone in patients with bronchial asthma are behavioral factors — smoking, drinking alcohol, strongly cooled drinks and violation of the safe use of the inhaler, creating serious prerequisites for the development of this pathology. The high frequency of EGDZ lesions in patients with bronchial asthma correlates with the duration of administration and doses of glucocorticosteroid therapy, which emphasizes its role as a trigger for the development of the pathology of the Esophagogastroduodenal zone.